ReviewCellular & molecular biology letters2021

Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy.

Jianan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.